Working groups
Paul Gilson is a molecular biologist primarily interested in how malaria parasites invade and thrive in human red blood cells and avoid host immunity.
Improving our understanding of these basic cellular processes will greatly accelerate our efforts to develop new drugs and vaccines to combat this devastating disease.
Paul R. Gilson
Paul R. Gilson
Nature Communications
Madeline G. Dans, Coralie Boulet, Somya Mehra, Zahra Razook, Dawson B. Ling, Thorey K. Jonsdottir, Alyssa E. Barry, Brendan S. Crabb, Paul R. Gilson
Drugs are the main weapons used to combat malaria infection. However, parasites are becoming resistant and new medicines and drug targets are needed.
This project aims to understand how novel mutations will affect malaria parasites from West Africa.
Drugs are the main weapons used to combat malaria infection, but parasites are becoming resistant and new medicines and drug targets are needed.
We work with medicinal chemists to develop new antimalarials that are effective against already multi-drug resistant parasites.